Log in to search using one of your social media accounts:

 

USFDA gives final nod to Glenmark Pharma for anti-herpes drug
Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Acyclovir Ointment USP. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 2, 2017 Category: Pharmaceuticals Source Type: news

Zovirax Injection (Acyclovir for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 2, 2017 Category: Drugs & Pharmacology Source Type: news

Zovirax Cream (Acyclovir Cream, 5%) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 2, 2017 Category: Drugs & Pharmacology Source Type: news

N.J.-based Amneal Pharmaceuticals could sell for as much as $8 billion
Swiss drug company Novartis AG is nearing an agreement to buy New Jersey-based Amneal Pharmaceuticals for $8 billion. There has not been a decision yet as Amneal could potentially be a target for other suitors, according to Bloomberg News, citing anonymous sources. Amneal, based in Bridgewater, is known for making numerous generic medicines, including gabapentin for epilepsy and pain, and acyclovir, a treatment for herpes as well as. A family-owned business since it was founded in 2002, Amneal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 14, 2016 Category: Biotechnology Authors: Anthony Noto Source Type: news

Xerese (Acyclovir and Hydrocortisone Cream) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Sitavig (Acyclovir Buccal Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Zovirax Ointment (Acyclovir Ointment) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 22, 2016 Category: Drugs & Pharmacology Source Type: news

Cadila gets USFDA nod to sell generic anti-viral drug
Cadila Healthcare has received approval from the US health regulator USFDA to market anti-viral generic Acyclovir capsules in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 29, 2016 Category: Pharmaceuticals Source Type: news

Don’t shrug off shingles
If you had chickenpox as a kid, there is a good chance you may develop shingles later in life. “In fact, one in three is predicted to get shingles during their lifetime,” says Dr. Anne Louise Oaklander, director of the Nerve Unit at Harvard-affiliated Massachusetts General Hospital. The same varicella-zoster virus that causes chickenpox also causes shingles. After the telltale spots of chickenpox vanish, the virus lies dormant in your nerve cells near the spinal cord and brain. When your immunity weakens from normal aging or from illnesses or medications, the virus can re-emerge. It then travels along a nerve t...
Source: New Harvard Health Information - February 18, 2016 Category: Consumer Health News Authors: Matthew Solan Tags: Healthy Aging Infectious diseases Vaccines Source Type: news

Guideline Updates: Adult & Adolescent OI Guideline
Authors of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently released updates to the following sections: HPV - This update provides new recommendations regarding the cervical cancer screening interval for HIV-positive women after 3 consecutive normal Pap tests, and the use of HPV co-testing among HIV-positive  women>30 years of age. It additionally includes recommendations regarding the use of 9-valent HPV vaccine among HIV-positive females and males ages 9-26 to prevent HPV infection. HSV - This update provides new information rega...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

PAS: Use high-dose acyclovir to treat HSV-infected infants
SAN DIEGO – Infants given high-dose acyclovir for the treatment of herpes simplex virus (HSV) infections experienced a number of adverse reactions, including seizure, hypotension, and thrombocytopenia, according to the results of a new study, but it is unclear if the root cause of these events is... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 21, 2015 Category: Dermatology Tags: FPN Conferences PED Conferences SAN Conference News FPN News FPN Child & Adolescent Medicine FPN Dermatology FPN Infectious Diseases PED News Source Type: news

acyclovir, Zovirax
Title: acyclovir, ZoviraxCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/27/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 27, 2015 Category: Drugs & Pharmacology Source Type: news

What Causes Vesicular Exanthams?
Discussion Vesicles are circumscribed, elevated, fluid-filled lesions 1 cm and often easily rupture due to their thin walls. The differential diagnosis is different for bullae than for vesicular lesions and is often more ominous including such diseases as Steven-Johnson, staphylococcal scalded skin and meningococcemia. Vesicular or bullous exanthems should be investigated more extensively if there is skin sloughing, petechiae or purpura, fever and irritability, inflammation of the mucosa, urticaria, has respiratory distress, and diarrhea or abdominal pain. Learning Point The differential diagnosis for vesicular exanthems ...
Source: PediatricEducation.org - March 2, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Enzyme inhibitors suppress herpes simplex virus replication, study finds
A family of molecules known as NTS enzyme inhibitors are promising candidates for new herpes virus treatments, a new study shows. The findings could lead to new treatment options for herpes that patients can use in conjunction with or instead of currently approved anti-viral medications like Acyclovir. Researchers likened a combination of treatments for herpes to a cocktail of medications HIV patients take. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 18, 2014 Category: Science Source Type: news

Zydus Cadila gets USFDA approval for anti-viral drug Acyclovir
Pharmaceutical major Zydus Cadila has received final approval from United States Food & Drug Administration for marketing of Acyclovir. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2014 Category: Pharmaceuticals Source Type: news

Xerese for the Treatment of Herpes LabialisXerese for the Treatment of Herpes Labialis
What you need to know about Xerese, a topical combination acyclovir-hydrocortisone product for treating herpes labialis, commonly known as cold sores. What other therapies have proven effective? Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2014 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

acyclovir, Zovirax
Title: acyclovir, ZoviraxCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/24/2014 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - July 24, 2014 Category: OBGYN Source Type: news

Zovirax Cream (Acyclovir Cream, 5%) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 15, 2014 Category: Drugs & Pharmacology Source Type: news

Genital Herpes: When Can I Stop Taking Acyclovir? polyDNA Answers...
In its latest December, 2013 survey, polyDNA found that up to 82% of respondents wanted to know when they could stop taking Acyclovir against their herpes infection. polyDNA reviews the literature on...(PRWeb January 27, 2014)Read the full story at http://www.prweb.com/releases/2014/01/prweb11515762.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2014 Category: Pharmaceuticals Source Type: news

Study: Acyclovir is Losing Effectiveness; CBCD Recommends Developing...
A new study published in the medical journal RSC Advances said that natural products have the potential to result in a comprehensive, anti-herpes therapy (1). The Center for the Biology of Chronic...(PRWeb October 04, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11192804.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2013 Category: Pharmaceuticals Source Type: news

Sitavig (Acyclovir) - Treatment for Herpes Labialis
Sitavig (acyclovir) is a muco-adhesive buccal tablet indicated for the treatment of recurring Herpes Labialis. The drug is manufactured and marketed by BioAlliance Pharma. (Source: Drug Development Technology)
Source: Drug Development Technology - July 29, 2013 Category: Pharmaceuticals Source Type: news

Sitavig (Acyclovir Buccal Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 29, 2013 Category: Drugs & Pharmacology Source Type: news